Supporting Colorectal Examination and Education Now Act of 2015
A BILL
To amend titles XI and XVIII of the Social Security Act and title XXVII of the Public Health Service Act to improve coverage for colorectal screening tests under Medicare and private health insurance coverage, and for other purposes.
Sec. 2 Findings
Sec. 3 Maintaining calendar year 2015 Medicare reimbursement rates for colonoscopy procedures for providers participating in colorectal cancer screening quality improvement registry
“(F) Maintaining calendar year 2015 reimbursement rates for qualifying cancer screening tests furnished by qualifying providers
“(i) In general—With respect to a qualifying cancer screening test furnished during each of 2016, 2017, and 2018, by a qualifying provider, the amount of payment to such provider for such test under section 1833 or section 1848 shall be equal to the amount of payment for such test under such section 1833 or 1848 during 2015.
“(ii) Qualifying cancer screening test—For purposes of this subparagraph, the term qualifying cancer screening test means an optical screening colonoscopy (as described in section 1861(pp)(1)(C)).
“(iii) Qualifying provider defined—For purposes of this subparagraph, the term qualifying provider means, with respect to a qualifying cancer screening test, an individual or entity—
“(I) that is eligible for payment for such test under section 1833 or section 1848; and
“(II) that—
“(aa) participates in a nationally recognized quality improvement registry with respect to such test; and
“(bb) demonstrates, to the satisfaction of the Secretary, based on the information in such registry, that the tests were provided by such individual or entity in accordance with accepted outcomes-based quality measures.”
Sec. 4 Eliminating Medicare beneficiary cost-sharing for certain colorectal cancer screenings, colorectal cancer screenings with therapeutic effect, and follow-up diagnostic colorectal cancer screenings covered under Medicare
Sec. 5 Medicare demonstration project to evaluate the effectiveness of a pre-operative visit prior to screening colonoscopy and hepatitis C screening
“(D) Medicare demonstration project to evaluate the effectiveness of a pre-operative visit prior to screening colonoscopy and hepatitis C screening
“(i) In general—The model described in this subparagraph is a demonstration project under title XVIII to evaluate the effectiveness of a pre-operative visit with the provider performing the procedure prior to screening colonoscopy to—
“(I) ease any patient concern or fears with respect to the procedure and answer any questions relating to the screening;
“(II) ensure quality examinations and avoid unnecessary repeat examinations by educating individuals on the importance of following pre-procedure instructions, such as bowel preparation, and addressing the individual's family history of or predisposition to colorectal cancer; and
“(III) increase Hepatitis C Virus (HCV) screening rates among Medicare beneficiaries by educating individuals about the importance of such screening during the pre-operative visit and having the pre-operative visit fulfill the referral requirement for such screening under title XVIII, allowing patients to be screened for colorectal cancer and HCV at the same time.
“(ii) Consultation—The Secretary shall consult with stakeholders who would be providing the pre-operative visit under the model described in this subparagraph on the implementation of such model, including payment for services furnished under the model.”